nd so, another workweek will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Once again, our agenda is rather modest. We plan to check in on the Pharmalot ancestors, hang with our short people, and search for the Great Pumpkin. And what about you? This remains a delightful time of year to enjoy the great outdoors. You could take a long, rambling drive somewhere or perhaps you would like to pick a few apples. Or you could simply stop to count your blessings. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon…

A Chicago federal jury decided that AbbVie should pay more than $140 million to a man after finding the company failed to properly test its AndroGel drug for an increased risk of heart attack and misrepresenting its safety for treating a decrease in testosterone caused by age. This is the second verdict against AbbVie to emerge from more than 6,000 similar lawsuits against AbbVie and other companies consolidated in the court, Reuters notes.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Pharmaceutical production
Drug Pricing

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.